Department of Radiation Oncology;
Yonsei Cancer Center;
Yonsei University College of Medicine;
Seoul 03722;
South Korea;
Hepatocellular carcinoma; Immune checkpoint inhibitor; Radiotherapy; Immune modulation; Tumor microenvironment; Immune oncology;